FDA Inspection 1096301 — Columbus Center For Reproductive Endocrinology & Infertility, LLC
The FDA completed an inspection of Columbus Center For Reproductive Endocrinology & Infertility, LLC on Jun 6, 2019 in Columbus, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 6, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Columbus, GA (United States)